Ontology highlight
ABSTRACT: Background and purpose
Intestinal mucositis refers to mucosal damage caused by cancer treatment, and irinotecan is one of the agents most associated with this condition. Focusing on the development of alternatives to prevent this important adverse effect, we evaluated the activity of the flavonoid luteolin, which has never been tested for this purpose despite its biological potential.Experimental approach
The effects of luteolin were examined on irinotecan-induced intestinal mucositis in mice. Clinical signs were evaluated. Moreover, histological, oxidative, and inflammatory parameters were analysed, as well as the possible interference of luteolin in the anti-tumour activity of irinotecan.Key results
Luteolin (30 mg·kg-1 ; p.o. or i.p.) prevented irinote
SUBMITTER: Boeing T
PROVIDER: S-EPMC7174882 | biostudies-literature | 2020 May
REPOSITORIES: biostudies-literature